EUVIMEDEUVIMED entdecken
Crossref

Global, regional, and national burden of fungal skin diseases in 204 countries and territories from 1990 to 2021: An analysis of the global burden of disease study 2021

Qinglian Qin iD, Jinming Su, Jie Liu, Rongfeng Chen, Wudi Wei, Zongxiang Yuan, Shiyi Lai, Ran Duan, Jingzhen Lai, Li Ye, Hao Liang, Junjun Jiang

Mycoses · 2024-08 · 67 (8)

DOI: 10.1111/myc.13787 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mycoses, online erschienen am 13.08.2024. Verfasst von Qinglian Qin und 11 weiteren Autor:innen. Beteiligte Einrichtung: Guangxi Key Laboratory of AIDS Prevention and Treatment, School of Public Health, Guangxi Medical University, Nanning, Guangxi, China. Hauptthemen laut MEDLINE: Global Burden of Disease, Dermatomycoses, Global Health. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Guangxi Science and Technology Planning Project, Guangxi Medical University Training Program for Young Leading Talents (to Junjun Jiang), Guangxi Medical University Training Program for Distinguished Young Scholars (to Junjun Jiang).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Fungal skin diseases are common skin diseases with a heterogeneous distribution worldwide.

Objectives

This study aimed to analyse the spatiotemporal trends in the burden of fungal skin diseases at global, regional, and national levels from 1990 to 2021.

Methods

Based on the data obtained from the Global Burden of Disease Study (GBD) 2021, we described the incident cases, prevalent cases, number of disability‐adjusted life years (DALYs), and corresponding age‐standardised rates (ASRs) for fungal skin diseases in 1990 and 2021 by sex, age, socio‐demographic index (SDI), 21 GBD regions, and 204 countries and territories. We used Joinpoint regression analysis to assess the temporal trends in burden of fungal skin diseases during 1990 to 2021. Spearman's rank test was used to analyse the relationship between disease burden and potential factors.

Results

From 1990 to 2021, the incident cases, prevalent cases, and DALYs for fungal skin diseases worldwide increased by 67.93%, 67.73%, and 66.77%, respectively. Globally, the age‐standardised incidence rate (ASIR), age‐standardised prevalence rate (ASPR), and age‐standardised DALYs rate (ASDR) for fungal skin diseases in 2021 were 21668.40 per 100,000 population (95% UI: 19601.19–23729.17), 7789.55 per 100,000 population (95% UI: 7059.28–8583.54), and 43.39 per 100,000 population (95% UI: 17.79–89.10), respectively. Between 1990 and 2021, the ASIR, ASPR, and ASDR for fungal skin diseases have modestly increased, with AAPC of 11.71% (95% confidence interval [CI]: 11.03%–12.39%), 19.24% (95% CI: 18.12%–20.36%), and 20.25% (95% CI: 19.33%–21.18%), respectively. Males experienced a higher burden of fungal skin diseases than females. The incident cases, prevalent cases, and DALYs for fungal skin diseases were highest at the age of 5–9, while the ASRs were highest among the elderly. At national level, the highest ASRs were observed in Nigeria, Ethiopia, and Mali. Overall, SDI was negatively correlated with the ASRs, whereas Global Land‐Ocean Temperature Index (GLOTI) was remarkably positively correlated with the burden of fungal skin diseases.

Conclusions

Between 1990 and 2021, the global burden of fungal skin diseases has increased, causing a high disease burden worldwide, particularly in underdeveloped regions and among vulnerable population such as children and the elderly. With global warming and aging of the population, the burden of fungal skin diseases may continue to increase in the future. Targeted and specific measures should be taken to address these disparities and the ongoing burden of fungal skin diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Global Burden of DiseaseDermatomycosesGlobal HealthHumansMaleFemaleAdultMiddle AgedPrevalenceIncidenceYoung AdultAdolescentAgedDisability-Adjusted Life YearsChild, PreschoolChildInfantInfant, NewbornAged, 80 and overCost of Illness

Stichwörter der Autor:innen

disability‐adjusted life yearsfungal skin diseasesglobal burden of diseaseincidenceprevalence

Autor:innen und Institutionen

  • Guangxi Key Laboratory of AIDS Prevention and Treatment, School of Public Health, Guangxi Medical University, Nanning, Guangxi, China.
  • China (Guangxi)-ASEAN Joint Laboratory of Emerging Infectious Diseases, Life Sciences Institute, Guangxi Medical University, Nanning, Guangxi, China.

ORCID-Profile: Qinglian Qin

Förderung

  • Guangxi Science and Technology Planning Project
  • Guangxi Medical University Training Program for Young Leading Talents (to Junjun Jiang)
  • Guangxi Medical University Training Program for Distinguished Young Scholars (to Junjun Jiang)
  • Scientific Research and Technology Development Program of Guangxi Zhuang Autonomous Region

Zitieren

APA

Qin, Q., Su, J., Liu, J., Chen, R., Wei, W., Yuan, Z., Lai, S., Duan, R., Lai, J., Ye, L., Liang, H., & Jiang, J. (2024). Global, regional, and national burden of fungal skin diseases in 204 countries and territories from 1990 to 2021: An analysis of the global burden of disease study 2021. Mycoses, 67(8). https://doi.org/10.1111/myc.13787

Vancouver

Qin Q, Su J, Liu J, Chen R, Wei W, Yuan Z, et al. Global, regional, and national burden of fungal skin diseases in 204 countries and territories from 1990 to 2021: An analysis of the global burden of disease study 2021. Mycoses. 2024;67(8). doi:10.1111/myc.13787

BibTeX
@article{Qin2024,
  author = {Qin, Qinglian and Su, Jinming and Liu, Jie and Chen, Rongfeng and Wei, Wudi and Yuan, Zongxiang and Lai, Shiyi and Duan, Ran and Lai, Jingzhen and Ye, Li and Liang, Hao and Jiang, Junjun},
  title = {Global, regional, and national burden of fungal skin diseases in 204 countries and territories from 1990 to 2021: An analysis of the global burden of disease study 2021},
  journal = {Mycoses},
  year = {2024},
  volume = {67},
  number = {8},
  doi = {10.1111/myc.13787}
}
Kostenlos starten →